2-methylthiopyrrolidines and their use for modulating bacterial quorum sensing
Compounds of Formula (I) are disclosed herein and their use in inhibiting quorum sensing in bacteria.
1. A compound having a structure of formula (I):
wherein
R 1 is OH and R 2 is H, or R 1 and R 2 taken together are oxo;
R 3 is selected from the group consisting of C 7 -C 20 alkyl, C 1 -C 20 alkyleneCO 2 H, C 1 -C 20 alkyleneCO 2 —C 1 -C 3 alkyl, C 1 -C 20 alkyleneCO 2 —C 5 -C 6 alkyl, C 1 -C 4 alkyleneCO 2 —C 1 -C 6 alkyl, C 6 -C 20 alkyleneCO 2 —C 1 -C 6 alkyl, and C 1 -C 20 alkylene-amino, and the alkyl or alkylene group of R 3 does not comprise a carbon-carbon double bond and is not further substituted;
R 4 and R 5 are each independently H or OH, or R 4 and R 5 taken together with the carbons that they are attached form a 4-7 membered cyclic or heterocyclic ring, and the ring is not further substituted;
X is NR 6 ; and
R 6 is H;
or a salt or ester thereof.
2. A compound having a structure of formula (I):
wherein:
R 1 and R 2 are each independently H or OH, or R 1 and R 2 taken together are oxo;
R 3 is selected from the group consisting of C 7 -C 20 alkyl, C 1 -C 20 alkyleneCO 2 H, C 1 -C 20 alkyleneCO 2 —C 1 -C 3 alkyl, C 1 -C 20 alkyleneCO 2 —C 5 -C 6 alkyl, C 1 -C 4 alkyleneCO 2 —C 1 -C 6 alkyl, C 6 -C 20 alkyleneCO 2 —C 1 -C 6 alkyl, and C 1 -C 20 alkylene-amino, and the alkyl or alkylene group of R 3 does not comprise a carbon-carbon double bond and is not further substituted;
both R 4 and R 5 are OH;
X is NR 6 ; and
R 6 is H;
or a salt or ester thereof.
3. The compound of claim 1 , wherein both R 4 and R 5 are H.
4. The compound of claim 1 , wherein R 3 is C 7 -C 20 alkyl.
5. The compound of claim 1 , wherein R 3 is selected from the group consisting of C 1 -C 20 alkyleneCO 2 H, C 1 -C 20 alkyleneCO 2 —C 1 -C 3 alkyl, C 1 -C 20 alkyleneCO 2 —C 5 -C 6 alkyl, C 1 -C 4 alkyleneCO 2 —C 1 -C 6 alkyl, C 6 -C 20 alkyleneCO 2 —C 1 -C 6 alkyl and C 1 -C 20 alkylene-amino.
6. A method of inhibiting bacterial quorum sensing or inhibiting formation of a biofilm comprising contacting bacteria with the compound of claim 1 .
7. The method of claim 6 , wherein the bacteria is selected from the group consisting of: Acinetobacter baumannii, Aeromonas hydrophila, Aeromonas salmonicida, Agrobacterium tumefaciens, Brucella melitensis, Burkholderia cenocepacia, Burkholderia mallei, Burkholderia pseudomallei, Burkholderia vietnamiensis, Chromobacterium violaceum, Enterobacter agglomeran, Erwinia carotovora, Erwinia chrysanthemi, Escherichia coli, Nitrosomas europaea, Obesumbacterium proteus, Pantoea agglomerans, Pantoea stewartii, Pseudomonas aureofaciens, Pseudomonas aeruginosa, Pseudomonas fluorescens, Pseudomonas fuscovaginae, Pseudomonas syringae, Ralstonia solanacearum, Rhizobium etli, Rhizobium leguminosarum, Rhodobacter sphaeroides, Serratia liquefaciens, Serratia marcescens, Vibrio anguillarum, Vibrio fischeri, Vibrio parahaemolyticus, Vibrio salmonicida, Xanthomonas campestris, Xenorhabdus nematophilus, Yersinia enterocolitica, Yersinia pestis, Yersinia pseudotuberculosis, Yersinia medievalis, Yersinia ruckeri , and combinations thereof.
8. The method of claim 6 , wherein the contacting comprises administering the compound or the composition to a subject suffering from a bacterial infection.
9. The method of claim 8 , further comprising administering a second agent to the subject.
10. The method of claim 9 , wherein the second agent is an antibiotic selected from the group consisting of a penicillin, a selexid, a cephalosporin, a tetracycline, a rifamycin, gentamycin, clindamycin, a fluoroquinolone, a monobactamer, a carbapeneme, a macrolide, a polymyxin, an aminoglycoside, tobramycin, a sulfonamide, a fusidine, a vancomycin, an oxazolidinone, a metronidazole, a corticosteroid, hydrocortisone, triamcinolone, betamethasone, and combinations thereof.
11. A method of treating a subject suffering from an infection comprising administering to the subject an effective amount of the compound of claim 1 .
12. The method of claim 11 , further comprising administering to the subject a second therapeutic, wherein the second therapeutic is an antibiotic.
13. The method of claim 12 , wherein the antibiotic is selected from a penicillin, a selexid, a cephalosporin, a tetracycline, a rifamycin, gentamycin, clindamycin, a fluoroquinolone, a monobactamer, a carbapeneme, a macrolide, a polymyxin, an aminoglycoside, tobramycin, a sulfonamide, a fusidine, a vancomycin, an oxazolidinone, a metronidazole, a corticosteroid, hydrocortisone, triamcinolone, betamethasone, and combinations thereof.
14. The method of claim 11 , wherein the infection is a P. aeruginosa infection.
15. A compound having a structure of formula (II):
wherein
R 1 and R 2 are each independently H or OH, or R 1 and R 2 taken together are oxo;
R 3 is selected from the group consisting of C 3 -C 20 alkyl, C 1 -C 20 alkyleneCO 2 H, C 1 -C 20 alkyleneCO 2 —C 1 -C 6 alkyl and C 1 -C 20 alkylene-amino, and the alkyl or alkylene group of R 3 does not comprise a carbon-carbon double bond and is not further substituted;
R 4 and R 5 are each independently H or OH, wherein at least one of R 4 and R 5 is OH;
X is NR 6 ; and
R 6 is H;
or a salt or ester thereof.
16. A compound having a structure of formula (III):
wherein
R 1 and R 2 are each independently H or OH, wherein at least one of R 1 and R 2 is OH or R 1 and R 2 taken together are oxo;
R 3 is selected from the group consisting of C 3 -C 20 alkyl, C 1 -C 20 alkyleneCO 2 H, C 1 -C 20 alkyleneCO 2 —C 1 -C 6 alkyl and C 1 -C 20 alkylene-amino, and the alkyl or alkylene group of R 3 does not comprise a carbon-carbon double bond and is not further substituted;
R 4 and R 5 are each independently H or OH, or R 4 and R 5 taken together with the carbons that they are attached form a 4-7 membered cyclic or heterocyclic ring, and the ring is not further substituted;
X is NR 6 ; and
R 6 is C(O)alkyl, and the alkyl group of R 6 is not further substituted; or a salt or ester thereof.
17. A method of inhibiting bacterial quorum sensing or inhibiting formation of a biofilm comprising contacting bacteria with the compound of claim 15 .
18. A method of inhibiting bacterial quorum sensing or inhibiting formation of a biofilm comprising contacting bacteria with the compound of claim 16 .
19. A method of treating a subject suffering from an infection comprising administering to the subject an effective amount of the compound of claim 15 .
20. A method of treating a subject suffering from an infection comprising administering to the subject an effective amount of the compound of claim 16 .
21. A method of inhibiting bacterial quorum sensing or inhibiting formation of a biofilm comprising contacting bacteria with the compound of claim 2 .
22. A method of treating a subject suffering from an infection comprising administering to the subject an effective amount of the compound of claim 2 .